Wednesday, December 4

Healthcare

Krystal Biotech's Jeune reports promising phase 1 data on wrinkles drug

08/29/20241 Min Read

Biotech039s data drug Jeune Krystal Phase promising reports wrinkles

Previous ArticleFDA accepts SpringWorks' application for mirdametinib for NF1-PN

Next Article Patterson Cos. stock falls 13% on fiscal Q1 earnings report